Yeah Billy! I believe you're right on with the $40pps.
My factors bring us a little higher so bear with me here:[/quote]We do have a modest OS (outstanding share count) by comparison to many who've been trying to go big time at this time (~ 17.22M; Public Float 14.68M)
• AND no delutive S1 finance offerings(at the time.
How close, or over a billion $ is an Alzheimers's stabilization therapy worth.
So a $58 pps =/~$1 Billion for our gushing Texas oil well. Couple recent transactions over in cancer cures show mulitple $BILLIONS aren't out of the question.
____________________
Bristol-Myers Squibb announced in January it would buy Celgene Corp in a cash-and-stock deal for about $74 billion, combining two of the world’s largest cancer drug businesses in the biggest pharmaceutical deal ever.
Amgen has agreed to buy Celgene’s Otezla business, the company said in a statement. The Otezla sale was valued at $13.4 billion.
______________________
PT*-125 as an Alzheimer's remedial lessening of the crippling disease vs. Otezla for psoriasis and skin inflamation (admittedly also crippling). HMMM. I honestly feel $58-$60.00 pps is reasonalbe. That puts our Texas gusher at a $1 Billion market cap.)
(*PT originally Pain Technology)
My thoughts.
GLTA
News 
Market Data 
Discover 
